Benchmark downgraded Repligen to Hold from Buy as the stock has exceeded the firm’s prior $160 price target, which has been removed. The current share price represents a valuation of 15 times estimated revenues for 2023 and at this time the firm is not adjusting its Q4 estimates of $152M in revenues and adjusted earnings per share of 30c, the analyst noted.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RGEN:
- UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report
- Repligen announces publication of 2022 sustainability report
- Repligen Announces Publication of the Company’s 2022 Sustainability Report
- Repligen price target lowered to $150 from $165 at Deutsche Bank
- Repligen to present at two upcoming investor conferences
